多方面的生物标志物表明,中枢神经系统病理在复发性和渐进性MS中具有相似的特征
Katelijn M Blok1,2, Romy A M Klein Kranenbarg1,2, Kirtana Ananth3
1Department of Neurology, MS Center ErasMS, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
European journal of neurology
|February 5, 2025
概括
生物标志物不能区分复发性缓解性硬化症 (RRMS) 和初级渐进性多发性硬化症 (PPMS). 然而,它们反映了炎症和组织损伤,有可能改善未来的MS分类和治疗方法.
科学领域:
- 神经免疫学 神经免疫学
- 神经病理学神经病理学
- 生物标志物发现发现
背景情况:
- 复发性复发性硬化症 (RRMS) 和初级渐进性多发性硬化症 (PPMS) 呈现出不同的临床轨迹.
- 人们对RRMS和PPMS之间的病理生理学区别仍然不完全理解.
- 这项研究研究了可溶性生物标志物和死后病理学,以区分多发性硬化症亚型.
研究的目的:
- 为了比较RRMS,PPMS和其他神经系统疾病之间的病理成分.
- 为了确定MS亚型的独特生物标志物配置文件.
- 为了将生物标志物水平与疾病活性和残疾相关联.
主要方法:
- 从患有PPMS,RRMS,阿尔茨海默病 (AD),NMOSD和MOGAD的患者中收集了血清和脑脊液 (CSF).
- 测量中的生物标志物包括BCMA,sCD27,OPN,CHI3L1,GFAP,NfL和SNAP25.
- 来自RRMS和PPMS病例的死后脑组织中的量化淋巴细胞群和轴突密度.
主要成果:
- 在RRMS和PPMS之间没有发现可溶性或死后生物标志物的显著差异.
- 与AD患者相比,MS患者表现出不同的生物标志物概况.
- 像NfL和BCMA这样的生物标志物与疾病活性,炎症和残疾相关 (EDSS).
结论:
- 可溶性生物标志物和死后病理学并不能区分RRMS和PPMS.
- 生物标志物概况反映了MS中炎症和组织损伤的程度.
- 对MS相关炎症和损伤的进一步详细评估可以完善分类和治疗方法.
相关概念视频
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:35Long-term Potentiation
51.6K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
51.6K
01:19Multiple Sclerosis l: Introduction
31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31